The signaling landscape upstream of STAT3 consists of several modulators, including noncoding RNAs and small proteins, which control gene expression and epigenetic frameworks either by activating or inhibiting STAT3, thus affecting the development of gastric cancer. The gene discussed is STAT3; the disease is gastric cancer.